K 8794
Latest Information Update: 04 Dec 2003
Price :
$50 *
At a glance
- Originator Kowa
- Class Antihypertensives
- Mechanism of Action Endothelin B receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Heart failure
Most Recent Events
- 04 Dec 2003 No development reported - Preclinical for Heart failure in Japan (unspecified route)
- 01 Aug 2000 New profile
- 01 Aug 2000 Preclinical development for Heart failure in Japan (Unknown route)